Your browser doesn't support javascript.
loading
A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety.
Dubcenco, E; Beers-Block, P M; Kim, L P; Schotland, P; Levine, J G; McCloskey, C A; Bashaw, E D.
  • Dubcenco E; Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada.
  • Beers-Block PM; Rutgers, State University of New Jersey, The Biopharma Educational Initiative, Newark, New Jersey, USA.
  • Kim LP; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.
  • Schotland P; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Levine JG; Rutgers, State University of New Jersey, The Biopharma Educational Initiative, Newark, New Jersey, USA.
  • McCloskey CA; Rutgers, State University of New Jersey, The Biopharma Educational Initiative, Newark, New Jersey, USA.
  • Bashaw ED; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.
Clin Transl Sci ; 10(5): 387-394, 2017 Sep.
Article en En | MEDLINE | ID: mdl-28618191
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de la Bomba de Protones Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de la Bomba de Protones Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article